WASHINGTON (AP) — Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant.
The company also said full results of its 2,250-person study …
This item is available in full to subscribers.
Please log in to continueDon't have an ID?Print subscribersIf you're a print subscriber, but do not yet have an online account, click here to create one. Non-subscribersClick here to see your options for becoming a subscriber. Click here to create a free account which will allow access to 5 stories every 30 days. |